HomeXBIT • NASDAQ
add
XBiotech Inc
Previous close
$2.25
Day range
$2.17 - $2.27
Year range
$2.09 - $3.62
Market cap
68.60M USD
Avg Volume
34.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.76M | 240.13% |
Net income | -26.89M | -155.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -29.38M | -253.56% |
Effective tax rate | -0.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 125.55M | -27.29% |
Total assets | 150.08M | -24.62% |
Total liabilities | 9.73M | -42.16% |
Total equity | 140.35M | — |
Shares outstanding | 30.49M | — |
Price to book | 0.49 | — |
Return on assets | -46.13% | — |
Return on capital | -48.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -26.89M | -155.92% |
Cash from operations | -22.95M | -250.95% |
Cash from investing | -34.00K | 59.52% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -21.82M | -108.95% |
Free cash flow | -13.54M | -136.67% |
About
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Founded
2005
Headquarters
Website
Employees
85
